Julia C. A. More

发表

Glutamate receptors ionotropic

D. Jane, D. Monaghan, Bihua Feng, 2005 .

Synthesis and pharmacology of willardiine derivatives acting as antagonists of kainate receptors.

G. Collingridge, D. Jane, Z. Bortolotto, 2005, Journal of medicinal chemistry.

Structure-activity relationship studies on N3-substituted willardiine derivatives acting as AMPA or kainate receptor antagonists.

G. Collingridge, D. Jane, D. Bleakman, 2006, Journal of medicinal chemistry.

Inhibition of Kainate Receptors Reduces the Frequency of Hippocampal Theta Oscillations

Robert U Muller, G. Collingridge, R. Muller, 2007, The Journal of Neuroscience.

The Different Effects on Recognition Memory of Perirhinal Kainate and NMDA Glutamate Receptor Antagonism: Implications for Underlying Plasticity Mechanisms

J. Aggleton, D. Jane, Z. Bashir, 2006, The Journal of Neuroscience.

Structural requirements for novel willardiine derivatives acting as AMPA and kainate receptor antagonists

D. Jane, Julia C. A. More, Nigel P. Dolman, 2003, British journal of pharmacology.

The novel antagonist 3‐CBW discriminates between kainate receptors expressed on neonatal rat motoneurones and those on dorsal root C‐fibres

D. Jane, Julia C. A. More, Helen M Troop, 2002, British journal of pharmacology.

Characterisation of UBP296: a novel, potent and selective kainate receptor antagonist

G. Collingridge, D. Jane, Z. Bortolotto, 2004, Neuropharmacology.

Kainate receptors and mossy fiber LTP.

G. Collingridge, D. Jane, Z. Bortolotto, 2005, Neurotoxicology.

Synthesis and pharmacological characterization of N3-substituted willardiine derivatives: role of the substituent at the 5-position of the uracil ring in the development of highly potent and selective GLUK5 kainate receptor antagonists.

G. Collingridge, M. Mayer, D. Jane, 2007, Journal of medicinal chemistry.

Activation of cyclic AMP-dependent protein kinase inhibits the desensitization and internalization of metabotropic glutamate receptors 1a and 1b.

S. Mundell, D. Jane, P. Roberts, 2004, Molecular pharmacology.